BioArctic and Eisai presented latest data regarding lecanemab at AD/PD 2021

Corporate Breaking News

Home : BioArctic and Eisai presented latest data regarding lecanemab at AD/PD 2021

Mar 15 2021	BioArctic and Eisai presented latest data regarding lecanemab at AD/PD 2021
STOCKHOLM, March 15, 2021 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced data on the drug candidate lecanemab (BAN2401), which were presented by the company and its partner Eisai at the 15th International Conference on Alzheimer's and Parkinson's Diseases...


Source:https://www.prnewswire.com:443/news-releases/bioarctic-and-eisai-presented-latest-data-regarding-lecanemab-at-adpd-2021-301247102.html

Related News
» Professional Physical Therapy Expands with New Clinic in Clark, NJ » Castellum invests SEK 154 million in new logistics building in Brunna, Stockholm